Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Smith Nephew ADR Representing 2 Ord Shs SNN

Healthcare Medical Devices

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee... see more

Add To Watchlist

Bullboard (NYSE:SNN)

View:

Post by whytestockson Jul 05, 2024 11:02am

Activist Investor Takes Stake In Sports Medicine Player Smit

NEWS: $SNN Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge | BenzingaShares of Smith @ Nephew Plc (NYSE:SNN) are trading higher on Friday. Smith+Nephew offers ...more

Post by prestedon Dec 28, 2023 10:19am

New acquisition bodes well

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that it has entered into a definitive agreement to acquire CartiHeal, developer of Agili-C, a novel sports ...more

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by willyk3on Oct 11, 2023 11:25am

RE:RE:Better earnings outlook

Patience is the word. Stock has been a real dud after that spring rally. Granted much of the market is down,especially dividend type stocks and also European stocks in general. Still I ...more

Discussion

Post by prestedon Apr 24, 2023 2:16pm

Newly introduced.

Monday, April 24, 2023, 8:00 AM ET Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty PR Newswire LONDON ...more

Comment by prestedon Mar 01, 2023 11:55am

RE:Better earnings outlook

It does bode well, but I always feel that management is a little stuffy and not as aggressive as it could be. Still, a safe investment and a fair yield so a good hold IMO. But it is not for those ...more

Discussion

Post by willyk3on Feb 21, 2023 3:02pm

Better earnings outlook

The stock gets a nice pop. Hope it bodes well for the next few years

144

Discussion

Comment by willyk3on Jan 31, 2023 6:16am

RE:Currency not company the problem here

Couldn't agree more. Time will tell

Discussion

Post by prestedon Nov 16, 2022 12:57pm

Currency not company the problem here

The drop in Sterling has been a factor in the decline of SNN. Great company, well managed and constant performer. Healthy dividend of 4% at today's SP. A keeper IMO.

143

Discussion

Post by radcaton Nov 01, 2022 8:24am

News!

Smith+Nephew expands procedural innovation with introduction of JOURNEY(TM) II ROX(TM) Total Knee Solution SNN | 23 minutes ago LONDON, Nov. 1 ...more

240

Comment by radcaton Nov 01, 2022 8:21am

RE:RE:RE:RE:RE:Div makes this attractive

ET reports earnings today after the close. Ex-dividend date is Nov 3rd, money in your account Nov 21st. Share price is currently up 22 cents to $12.99 U.S. in the aftermarket... So do you think SNN is ...more

Discussion

(0)
•••

Post by PressReleaseon Nov 01, 2022 8:00am

New Press Release - Smith+Nephew expands procedural innovation with introduction of JOURNEY(TM) II ROX(TM) Total Knee Solution

LONDON, Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide...read article.

Comment by prestedon Oct 31, 2022 12:17pm

RE:RE:RE:RE:Div makes this attractive

Thanks for the suggestion Rad, Incredible volume today of over 12 millionnahsre before noon. Seems the only fly in the ointment may be the Dakota Access Pipeline which a court has ruled an ...more

Discussion

Comment by radcaton Oct 30, 2022 11:15am

RE:RE:RE:Div makes this attractive

Since you are a Divi hound, check out Energy Transfer (ET). I have followed them since early 2022 when their share price was at $8.00 U.S. with a dividend of $0.62 U.S. The dividend has been raised ...more

Discussion

Comment by willyk3on Oct 30, 2022 10:56am

RE:RE:Div makes this attractive

Good for you rad. I filled my plate with SNN at slightly higher prices as I kept buying with each new low. Sitting tite now and as with many other stocks that are at multi year lows I am prepared to ...more

Discussion

Comment by radcaton Oct 30, 2022 10:07am

RE:Div makes this attractive

I am a new shareholder. Bought my shares a few days before the Sept 29th, the ex-dividend date. What I liked about SNN was... Covid-19 was made public on Jan 25th 2020, SNN share price on Jan 26th ...more

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Smith Nephew ADR Representing 2 Ord Shs SNN

Bullboard (NYSE:SNN)

Activist Investor Takes Stake In Sports Medicine Player Smit

New acquisition bodes well

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

RE:RE:Better earnings outlook

Newly introduced.

RE:Better earnings outlook

Better earnings outlook

RE:Currency not company the problem here

Currency not company the problem here

News!

RE:RE:RE:RE:RE:Div makes this attractive

New Press Release - Smith+Nephew expands procedural innovation with introduction of JOURNEY(TM) II ROX(TM) Total Knee Solution

RE:RE:RE:RE:Div makes this attractive

RE:RE:RE:Div makes this attractive

RE:RE:Div makes this attractive

RE:Div makes this attractive

Featured News Links

Discover Options Trading Strategies to Minimize your Tax Burden

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Smith Nephew ADR Representing 2 Ord Shs SNN

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (NYSE:SNN)

Featured News Links